STOCK TITAN

DocGo (DCGO) Stock News, May-Jun 2022

DCGO NASDAQ

DocGo Inc. reports developments in technology-enabled mobile health, medical transportation, remote patient monitoring and virtual care. The company’s care delivery platform combines in-home or workplace treatment with remote physicians, a 50-state virtual care network and integrated Ambulnz medical transport services.

Recurring news themes include quarterly and annual results, revenue guidance, customer expansions, EMS hiring and efficiency initiatives, investor conference presentations, governance and compliance recognition, and activity at SteadyMD, DocGo’s virtual care division. Company updates also describe demand for clinician-led telehealth programs, including branded GLP-1 weight loss care support.

Rhea-AI Summary

DocGo (NASDAQ: DCGO), a leader in last-mile mobile health services, has announced participation in two upcoming conferences. President Anthony Capone will join a panel discussion at the Cowen FutureHealth Conference on June 22 at 12:40 PM ET, while CEO Stan Vashovsky will attend the 8th Annual Roth London Conference on June 23, providing on-site medical services. DocGo specializes in integrated ambulance transportation and mobile health, aiming to disrupt traditional healthcare systems by offering affordable, high-quality care where patients need it.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.10%
Tags
none
-
Rhea-AI Summary

DocGo (NASDAQ: DCGO) will present at two conferences on June 7, 2022: Stifel 2022 Cross Sector Insight Conference in Boston at 3:35 PM ET and LD Micro Invitational in Westlake Village, CA at 4:30 PM ET. CEO Stan Vashovsky and Investor Relations Mike Cole will lead the presentations, which will be accessible via webcast on the company's investor relations website. DocGo specializes in last-mile mobile health services, aiming to provide affordable care outside traditional healthcare settings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
none
-
Rhea-AI Summary

DocGo (NASDAQ: DCGO) has authorized a $40 million share repurchase program, which reflects the Board's confidence in the company's growth and financial health. The firm reported $199 million in cash and equivalents, allowing for this buyback strategy. The program aims to enhance shareholder value and may involve various purchase methods, including open market transactions. It is set to expire on November 24, 2023. DocGo aims to leverage its strong cash flow and capital position to support this initiative.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.84%
Tags
buybacks
Rhea-AI Summary

DocGo (NASDAQ: DCGO) announced that President Anthony Capone will present at the H.C. Wainwright Global Investment Conference on May 24 at 7:00 A.M. ET. The presentation will be accessible via the investor relations section of DocGo’s website. The company specializes in last-mile mobile health services and integrated medical transportation solutions, leveraging innovative technology and a dedicated team to enhance patient care and operational efficiencies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.73%
Tags
none
-
Rhea-AI Summary

DocGo, a leader in mobile health services, has expanded its partnership with Carnival Corporation to provide on-ship health services at eight new cruise ports across the U.S., Canada, England, and Australia. This collaboration enhances passenger care by offering screenings and medical support during cruises. Since 2020, DocGo has facilitated over 182,000 patient interactions. The partnership signifies growth in onboard medical support staff and expanding service reach, aiming to ensure passenger health and safety during travel.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.54%
Tags
none
-
Rhea-AI Summary

DocGo (NASDAQ: DCGO), a leader in last-mile mobile health services, announced that CEO Stan Vashovsky and CFO Andre Oberholzer will present at the 17th Annual Needham Technology & Media Conference on Tuesday, May 17, at 2:15 PM Eastern Time. Investors can access a webcast of the event on DocGo's investor relations website. DocGo aims to disrupt traditional healthcare systems by providing integrated medical transportation and telehealth solutions, enhancing patient care and operational efficiency for healthcare providers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.31%
Tags
none
Rhea-AI Summary

DocGo (Nasdaq:DCGO) reported Q1 2022 revenue of $117.9 million, a remarkable 137% increase from $49.7 million in Q1 2021. The company estimates that $38 million of this revenue came from Covid testing.

Net income improved to $9.4 million, recovering from a $2.0 million loss a year prior. Mobile Health revenue surged to $90.1 million, while medical transport revenue rose by 46% to $27.8 million. The company maintains a revenue guidance of $400-420 million for 2022, projecting annual growth of 25-32%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.31%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.76%
Tags
none
-
Rhea-AI Summary

DocGo has announced a multi-year contract with Empire BlueCross BlueShield to offer mobile health services to an additional 4.5 million residents in New York. Starting June 1, 2022, this contract will enhance access to in-home medical care for commercial, Medicare, and Medicaid populations. DocGo aims to improve healthcare accessibility outside traditional facilities, aligning with Empire's mission to enhance the health of New Yorkers. This expansion signifies DocGo's growth momentum in the mobile healthcare sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.67%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.67%
Tags
none

FAQ

What is the current stock price of DocGo (DCGO)?

DocGo (DCGO) last closed at $0.1899.

What is the market cap of DocGo (DCGO)?

The market cap of DocGo (DCGO) is approximately $18.8M.